Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Completed Initiated May 5, 2021 (5 years ago)

BusPIRone Hydrochloride Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Tablets/Capsules

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

BusPIRone Hydrochloride Tablets, USP, 15 mg, 100-count bottle, Rx only, Manufactured By: Oxford Pharmaceuticals, LLC Birmingham, Alabama 35211, NDC 69584-093-10

Affected NDC 69584-0093-10

Compare with the code on your package — it is the most precise check available.

Drug: Iron

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Buspirone Hydrochloride
NDC 69584-0093
15 mg/1 Tablet
Oral
Oxford Pharmaceuticals, LLC Rx
Recalling firm
Oxford Pharmaceuticals, LLC
NDC code
69584-093-10
Origin
AL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0602-2021 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now completed, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Iron recalls

See all

Other particulate / foreign matter recalls from 2021

All particulate / foreign matter recalls
Class I · High risk

Veklury (remdesivir)

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 61958-2901-2 D-0299-2022
Class II · Moderate risk

Ezetimibe and Simvastatin Tablets

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Terminated Particulate / foreign matter Golden State Medical Supply Inc. D-0227-2022